Skip to main content
Mednow Inc. logo

Mednow Inc. — Investor Relations & Filings

Ticker · MNOW ISIN · CA58503L2021 TSXV Wholesale and retail trade
Open in API
Filings indexed 132 across all filing types
Latest filing 2023-03-31 Interim / Quarterly Rep…
Country CA Canada
Listing TSXV MNOW

About Mednow Inc.

https://mednow.ca/

Mednow Inc. is a full-service virtual pharmacy utilizing a digital-first approach to deliver prescription medications, over-the-counter products, and comprehensive health services. The company provides fast, free delivery of medications and health products. Core offerings include unlimited virtual consultations with certified pharmacists, prescription management tools accessible via web or mobile application, and direct billing to insurance providers. A key service is PillSmart®, which organizes multiple daily medications into convenient, single-dose packages at no additional cost. Mednow focuses on improving patient access and adherence by offering expert advice and medication reviews seven days a week.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of Mednow Inc.'s financial results for the quarter ended January 31, 2023 (Q2 2023). It includes comprehensive financial data such as revenue, EBITDA, adjusted EBITDA, segment performance, and reconciliations of non-IFRS financial measures. The text references the Management Discussion & Analysis (MD&A) and financial statements being available on SEDAR and the company's website, indicating this is a full quarterly financial report. The presence of detailed financial tables, explanations of financial metrics, and discussion of business operations and outlook confirms this is an Interim / Quarterly Report rather than a brief earnings release or a simple announcement. The document length (15,000 characters) and depth of financial data support classification as an Interim / Quarterly Report (IR).
2023-03-31 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Mednow Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended January 31, 2023. The document is a certification letter, not the interim report itself, and contains no substantive financial data or analysis. It explicitly states it is a certification under National Instrument 52-109 for venture issuers, which is an officer attestation. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR). The document length is short (3007 characters), and it is clearly a certification, not the report itself.
2023-03-31 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CEO of Mednow Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended January 31, 2023. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references an interim report but does not include the report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (3024 characters), consistent with a certification letter rather than a full report.
2023-03-31 English
Interim MD&A - English.pdf
Management Reports Classification · 100% confidence The document is titled 'Management’s Discussion and Analysis For the period ended January 31, 2023' and contains detailed discussion of the company's financial condition, results of operations, cash flows, strategic imperatives, and corporate developments. It references the six-month period ended January 31, 2023, and includes substantive financial and operational information. The document is clearly a Management Discussion and Analysis (MD&A) report, which is a detailed explanation of financial results and business trends. It is not an announcement or a brief summary, nor is it a transcript, audit report, or regulatory filing. Therefore, the appropriate classification is 'Management Reports' (MDA).
2023-03-31 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements' for the three and six months ended January 31, 2023 and 2022. It contains detailed financial statements including statements of financial position, loss and comprehensive loss, changes in shareholders' equity, and cash flows. The document is unaudited and prepared in accordance with IAS 34, which governs interim financial reporting. The length of the document is substantial (15,000 characters), and it contains actual financial data and analysis for a period shorter than a full fiscal year (six months). Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2023-03-31 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change event regarding the closing of a private placement offering of secured convertible debentures by Mednow Inc. It includes specifics about the offering, terms of the convertible debentures, use of proceeds, insider participation, and regulatory exemptions. The document is a regulatory filing reporting a material change event, not a full financial report, earnings release, or other report types. It is relatively short (3824 characters) and structured as a formal disclosure under Canadian securities regulations. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about a material change that does not fit other specific categories like capital update or financing update, since it is a formal material change report under NI 51-102. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-02-10 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.